Pharmaceutical industry
View all stories with this category.
-
-
OpinionIn search of ultimate selectivity
A catalyst that reacts only with aryl iodides, spurning bromides and chlorides
-
NewsBig costs, no benefits to UK’s replacement for EU chemical regulation
Industry warns small volume chemicals could no longer be sold in the UK
-
BusinessUK government sets out antimicrobial resistance plan
Aims to cut antibiotic use and explore financial incentives for pharmaceutical companies
-
BusinessBattling the US opioid epidemic
Adapt pharma’s naloxone nasal spray makes treating overdoses easier
-
ResearchPatent-busting AI tool navigates around protected drug pathways
Organic retrosynthesis software can identify key bonds involved in patented reactions to find alternative pathways
-
OpinionWhat are the rate-limiting steps in drug discovery?
Getting more drugs to market is not just a chemistry problem
-
BusinessPfizer to close two manufacturing plants in India
Closures will lead to the loss of 1700 jobs – almost 6% of the pharma giant’s manufacturing workforce
-
BusinessChinese plant closures disrupt supply chains
Environmental clampdown knocks out major suppliers of some ingredients
-
BusinessBristol-Myers Squibb to buy Celgene for $74 billion
Deal boosts BMS’s cancer and immunology pipeline with 5 drugs in late stage clinical trials
